These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23271118)

  • 1. The interaction between actin and FA fragment of diphtheria toxin.
    Unlü A; Bektaş M; Sener S; Nurten R
    Mol Biol Rep; 2013 Apr; 40(4):3135-45. PubMed ID: 23271118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of diphtheria toxin (fragment A) with actin.
    Bektaş M; Varol B; Nurten R; Bermek E
    Cell Biochem Funct; 2009 Oct; 27(7):430-9. PubMed ID: 19711484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxic effect of diphtheria toxin on the actin cytoskeleton.
    Varol B; Bektaş M; Nurten R; Bermek E
    Cell Mol Biol Lett; 2012 Mar; 17(1):49-61. PubMed ID: 22139586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin--an inhibitor of eukaryotic elongation factor activities.
    Bektaş M; Günçer B; Güven C; Nurten R; Bermek E
    Biochem Biophys Res Commun; 2004 May; 317(4):1061-6. PubMed ID: 15094376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-Binding and Uptake of Binary Actin-ADP-Ribosylating Toxins.
    Papatheodorou P; Aktories K
    Curr Top Microbiol Immunol; 2017; 406():119-133. PubMed ID: 27817176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M; Nurten R; Ergen K; Bermek E
    Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens iota-toxin.
    Tsuge H; Nagahama M; Oda M; Iwamoto S; Utsunomiya H; Marquez VE; Katunuma N; Nishizawa M; Sakurai J
    Proc Natl Acad Sci U S A; 2008 May; 105(21):7399-404. PubMed ID: 18490658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H; Iglewski WJ
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of threonine ADP-ribosylation of F-actin by a Tc toxin.
    Belyy A; Lindemann F; Roderer D; Funk J; Bardiaux B; Protze J; Bieling P; Oschkinat H; Raunser S
    Nat Commun; 2022 Jul; 13(1):4202. PubMed ID: 35858890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A; Balestrieri C; Quagliuolo L; Servillo L
    FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-ADP-ribosylation actin by Clostridium perfringens iota-toxin and Clostridium botulinum C2 toxin.
    Just I; Geipel U; Wegner A; Aktories K
    Eur J Biochem; 1990 Sep; 192(3):723-7. PubMed ID: 2145159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer modelling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
    Domenighini M; Montecucco C; Ripka WC; Rappuoli R
    Mol Microbiol; 1991 Jan; 5(1):23-31. PubMed ID: 1901617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for substrate recognition in the enzymatic component of ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
    Sundriyal A; Roberts AK; Shone CC; Acharya KR
    J Biol Chem; 2009 Oct; 284(42):28713-9. PubMed ID: 19692332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytochalasin D-stimulated G-actin ATPase by ADP-ribosylation with Clostridium perfringens iota toxin.
    Geipel U; Just I; Aktories K
    Biochem J; 1990 Mar; 266(2):335-9. PubMed ID: 2138453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.
    Barth H; Blöcker D; Aktories K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
    Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
    Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins.
    Deng Q; Barbieri JT
    Annu Rev Microbiol; 2008; 62():271-88. PubMed ID: 18785839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.